Analysis of biomarker utility using a PBPK/PD model for carbaryl

Por Phillips, Martin B., Yoon, Miyoung, Young, Bruce, Tan, Yu-Mei
Publicado no Front Pharmacol (2014)

Degraded protein adducts of cis-2-butene-1,4-dial are urinary and hepatocyte metabolites of furan

Por Lu, Ding, Sullivan, Mathilde M., Phillips, Martin B., Peterson, Lisa A.
Publicado em 2009

Polyamines are traps for reactive intermediates in furan metabolism

Por Peterson, Lisa A., Phillips, Martin B., Lu, Ding, Sullivan, Mathilde M.
Publicado em 2011

Covalent Modification of Cytochrome C by Reactive Metabolites of Furan

Por Phillips, Martin B., Sullivan, Mathilde M., Villalta, Peter W., Peterson, Lisa A.
Publicado em 2013

Comparative Metabolism of Furan in Rodent and Human Cryopreserved Hepatocytes

Por Gates, Leah A., Phillips, Martin B., Matter, Brock A., Peterson, Lisa A.
Publicado em 2014

Fluid Dynamic Modeling to Support the Development of Flow-Based Hepatocyte Culture Systems for Metabolism Studies

Por Pedersen, Jenny M., Shim, Yoo-Sik, Hans, Vaibhav, Phillips, Martin B., Macdonald, Jeffrey M., Walker, Glenn, Andersen, Melvin E., Clewell, Harvey J., Yoon, Miyoung
Publicado no Front Bioeng Biotechnol (2016)

A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome Pathways

Por Phillips, Martin B., Leonard, Jeremy A., Grulke, Christopher M., Chang, Daniel T., Edwards, Stephen W., Brooks, Raina, Goldsmith, Michael-Rock, El-Masri, Hisham, Tan, Yu-Mei
Publicado no Environ Health Perspect (2015)

Developing a Physiologically-Based Pharmacokinetic Model Knowledgebase in Support of Provisional Model Construction

Por Lu, Jingtao, Goldsmith, Michael-Rock, Grulke, Christopher M., Chang, Daniel T., Brooks, Raina D., Leonard, Jeremy A., Phillips, Martin B., Hypes, Ethan D., Fair, Matthew J., Tornero-Velez, Rogelio, Johnson, Jeffre, Dary, Curtis C., Tan, Yu-Mei
Publicado no PLoS Comput Biol (2016)